GLP-1s linked to nutritional deficiencies in children

Summary

A study published in Childhood Obesity found that 16.8% of children aged 10–17 prescribed GLP-1 medications for weight loss, prediabetes, or type 2 diabetes were diagnosed with a nutritional deficiency within their first year of treatment. Vitamin D deficiency was most common, affecting 12.4%. Researchers analyzed claims data for 2,031 pediatric GLP-1 users from 2017–2022. They also found limited nutritional counseling: 5% received it within 30 days and fewer than 25% within six months, prompting calls for proactive monitoring during growth and puberty.